PharmaCyte Biotech - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Netmarble Corporation bets on staged rollout to de-risk The Seven Deadly Sins: Origin open-world expansion

The real reason Netmarble is launching The Seven Deadly Sins: Origin in phases

Longeveron Inc. appoints Stephen H. Willard as CEO ahead of pivotal Phase 2b stem cell data

Philadelphia jury orders Johnson & Johnson to pay $250,000 in talc powder lawsuit

Representative image showing the intersection of financial performance and cancer diagnostics, reflecting Exact Sciences’ record 2025 results and its pending acquisition by Abbott Laboratories.

Exact Sciences (NASDAQ: EXAS) earnings show why Abbott moved now on a $21bn diagnostics acquisition

Read More

6 minute read

Pharma Industry News

PharmaCyte Biotech turns Femasys investment into cash windfall, fueling new strategic opportunities

Find out how PharmaCyte Biotech’s monetized Femasys stake strengthens liquidity and fuels new strategic opportunities.

bySoujanya Ravi

November 25, 2025

web analytics